-
Something wrong with this record ?
Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis
E. Mašková, K. Kubová, J. Vysloužil, S. Pavloková, D. Vetchý,
Language English Country United States
Document type Journal Article
- MeSH
- Hypromellose Derivatives * MeSH
- Gels MeSH
- Kinetics MeSH
- Hydrogen-Ion Concentration MeSH
- Delayed-Action Preparations chemistry MeSH
- Malates chemistry MeSH
- Multivariate Analysis MeSH
- Solubility MeSH
- Succinates chemistry MeSH
- Tablets MeSH
- Drug Liberation MeSH
- Verapamil administration & dosage chemistry metabolism MeSH
- Waxes * MeSH
- Publication type
- Journal Article MeSH
The solubility of weakly basic drugs in passage through gastrointestinal tract leads to their pH-dependent release from extended release formulations and to lower drug absorption and bioavailability. The aim of this study was to modulate the micro-environmental pH of hypromellose/montanglycol wax matrices and to observe its influence on the release of weakly basic drug verapamil hydrochloride (VH) with a pH-dependent solubility with respect to gel layer formation and its dynamics. For this study, malic and succinic acids differing in their solubility and pKa were selected as pH modifiers. The dissolution studies were performed by the method of changing pH. Within the same conditions, pH, thickness, and penetration force of the gel layer were measured as well. From the PCA sub-model, it is evident that a higher acid concentration ensured lower gel pH and conditions for higher drug solubility, thus creating larger gel layer with smaller rigidity, resulting in higher VH release during the dissolution test. Incorporation of stronger and more soluble malic acid (100 mg/tablet) created the most acidic and the thickest gel layer through which a total of 74% of VH was released. Despite having lower strength and solubility, matrices containing succinic acid (100 mg/tablet) released a comparable 71% of VH in a manner close to zero-order kinetics. The thinner and less rigid gel layers of the succinic acid matrices allowed an even slightly faster VH release at pH 6.8 than from matrices containing malic acid. Thus acid solubility is more parametrically significant than acid pKa for drug release at pH 6.8.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011096
- 003
- CZ-PrNML
- 005
- 20180413141114.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1208/s12249-016-0588-x $2 doi
- 035 __
- $a (PubMed)27474035
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mašková, Eliška $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42, Brno, Czech Republic.
- 245 10
- $a Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis / $c E. Mašková, K. Kubová, J. Vysloužil, S. Pavloková, D. Vetchý,
- 520 9_
- $a The solubility of weakly basic drugs in passage through gastrointestinal tract leads to their pH-dependent release from extended release formulations and to lower drug absorption and bioavailability. The aim of this study was to modulate the micro-environmental pH of hypromellose/montanglycol wax matrices and to observe its influence on the release of weakly basic drug verapamil hydrochloride (VH) with a pH-dependent solubility with respect to gel layer formation and its dynamics. For this study, malic and succinic acids differing in their solubility and pKa were selected as pH modifiers. The dissolution studies were performed by the method of changing pH. Within the same conditions, pH, thickness, and penetration force of the gel layer were measured as well. From the PCA sub-model, it is evident that a higher acid concentration ensured lower gel pH and conditions for higher drug solubility, thus creating larger gel layer with smaller rigidity, resulting in higher VH release during the dissolution test. Incorporation of stronger and more soluble malic acid (100 mg/tablet) created the most acidic and the thickest gel layer through which a total of 74% of VH was released. Despite having lower strength and solubility, matrices containing succinic acid (100 mg/tablet) released a comparable 71% of VH in a manner close to zero-order kinetics. The thinner and less rigid gel layers of the succinic acid matrices allowed an even slightly faster VH release at pH 6.8 than from matrices containing malic acid. Thus acid solubility is more parametrically significant than acid pKa for drug release at pH 6.8.
- 650 _2
- $a léky s prodlouženým účinkem $x chemie $7 D003692
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a gely $7 D005782
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 12
- $a deriváty hypromelózy $7 D065347
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a maláty $x chemie $7 D008293
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a sukcináty $x chemie $7 D013386
- 650 _2
- $a tablety $7 D013607
- 650 _2
- $a verapamil $x aplikace a dávkování $x chemie $x metabolismus $7 D014700
- 650 12
- $a vosky $7 D014885
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kubová, Kateřina $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42, Brno, Czech Republic. kubovak@vfu.cz.
- 700 1_
- $a Vysloužil, Jakub $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42, Brno, Czech Republic.
- 700 1_
- $a Pavloková, Sylvie $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42, Brno, Czech Republic.
- 700 1_
- $a Vetchý, David $u Department of Pharmaceutics, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1/3, 612 42, Brno, Czech Republic.
- 773 0_
- $w MED00008281 $t AAPS PharmSciTech $x 1530-9932 $g Roč. 18, č. 4 (2017), s. 1242-1253
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27474035 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180413141207 $b ABA008
- 999 __
- $a ok $b bmc $g 1288581 $s 1007908
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 18 $c 4 $d 1242-1253 $e 20160729 $i 1530-9932 $m AAPS PharmSciTech $n AAPS PharmSciTech $x MED00008281
- LZP __
- $a Pubmed-20180404